Orgenesis Stock (NASDAQ: ORGS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 90.77K |
Day Range | - - - |
52 Wk Range | 0.25 - 1.29 |
Market Cap | $36.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 0.65% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Orgenesis (NASDAQ:ORGS) through any online brokerage.
Other companies in Orgenesis’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).
There is no analysis for Orgenesis.
Orgenesis has a consensus price target of $6.00.
The stock price for Orgenesis (NASDAQ: ORGS) is $0.7799 last updated July 18, 2024 at 9:05 AM EDT.
There are no upcoming dividends for Orgenesis.
Orgenesis’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Orgenesis.
Orgenesis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.